ImmunoGenesis, Inc. logo

ImmunoGenesis, Inc.

Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mechanisms of immune resistance.

14 employees · est. 2019 · Houston, United States

VS
Shinobi Therapeutics logo

Shinobi Therapeutics

40 employees · est. 2023 · South San Francisco, United...

ImmunoGenesis, Inc. is the older company (2019 vs 2023).

Side-by-Side Comparison

ImmunoGenesis, Inc. Shinobi Therapeutics
Founded
2019 older 2023
Headquarters
Houston, United States South San Francisco, United States
Employees
14 40
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health and Wellness
Funding Stage
Series Unknown Series A
Total Funding
$28.00M $51.00M
Funding Rounds
4 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Immuno-oncology, Biopharmaceutical, Drug Development, Immune Resistance, Immune-excluded Tumors, Immunotherapy, Clinical-stage, Immune Response, Tumor Pathology, Cancer Treatment, Immune System, Therapy Development Immunotherapy, Cancer Treatment, Cell Therapy, Stem Cells, Immune System, IPSCs, Therapeutics, Immune Evasion, Innovation, Medical Research
Website
immunogenesis.com shinobitx.com
ImmunoGenesis, Inc. logo

About ImmunoGenesis, Inc.

ImmunoGenesis, Inc. is a clinical-stage immuno-oncology biopharmaceutical company focused on re-envisioning the treatment of "cold" tumors, particularly immune-excluded tumors. These tumors, which account for over half of all cancers, are resistant to current immunotherapies due to mechanisms that s...

Shinobi Therapeutics logo

About Shinobi Therapeutics

Shinobi Therapeutics is a biotechnology startup founded in 2023 and headquartered in the United States. The company is focused on developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond, leveraging immune evasion to unlock the full potential of iPSCs. The startup recently secur...

We will tell you when either one moves

BounceWatch watches ImmunoGenesis, Inc. and Shinobi Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at ImmunoGenesis, Inc. and Shinobi Therapeutics — by email.

Frequently Asked Questions

ImmunoGenesis, Inc. — Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mechanisms of immune resistance.. Shinobi Therapeutics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
ImmunoGenesis, Inc. has raised $28.00M while Shinobi Therapeutics has raised $51.00M.
ImmunoGenesis, Inc. and Shinobi Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare ImmunoGenesis, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at ImmunoGenesis, Inc. on 12 Sep 2024, and Shinobi Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes